Related references
Note: Only part of the references are listed.Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
Alberto Alonso-Ruiz et al.
BMC MUSCULOSKELETAL DISORDERS (2008)
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis
Marina Papoutsaki et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
HUMIRA® Pen:: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab
Alan Kivitz et al.
EXPERT REVIEW OF MEDICAL DEVICES (2007)
Multiple verrucous carcinomas treated with acitretin
Yue-Zon Kuan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Patient preferences in choosing anti-TNF therapies-R1
E. L. Williams et al.
RHEUMATOLOGY (2006)
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: The TOUCH trial
Alan Kivitz et al.
CLINICAL THERAPEUTICS (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Adalimuniab - In psoriatic arthritis
Dene Simpson et al.
DRUGS (2006)
The benefit/risk profile of TNF-blocking agents: Findings of a consensus panel
MC Hochberg et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy - A randomized, placebo-controlled, 52-week trial
EC Keystone et al.
ARTHRITIS AND RHEUMATISM (2004)
Does route of administration affect the outcome of TNF antagonist therapy?
S Schwartzman et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Adalimumab - A review of its use in rheumatoid arthritis
LM Bang et al.
BIODRUGS (2004)
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
MH Weisman et al.
CLINICAL THERAPEUTICS (2003)
Share Paper
